[go: up one dir, main page]

WO2005113765A3 - Procedes d'activation de sulfatases, methodes et compositions d'utilisation associees - Google Patents

Procedes d'activation de sulfatases, methodes et compositions d'utilisation associees Download PDF

Info

Publication number
WO2005113765A3
WO2005113765A3 PCT/US2005/014097 US2005014097W WO2005113765A3 WO 2005113765 A3 WO2005113765 A3 WO 2005113765A3 US 2005014097 W US2005014097 W US 2005014097W WO 2005113765 A3 WO2005113765 A3 WO 2005113765A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
sulfatases
activation
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/014097
Other languages
English (en)
Other versions
WO2005113765A2 (fr
Inventor
Todd Zankel
Gary Nicholas Zecherle
Christopher M Starr
Teresa Margaret Christianson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomarin Pharmaceutical Inc
Original Assignee
Biomarin Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomarin Pharmaceutical Inc filed Critical Biomarin Pharmaceutical Inc
Publication of WO2005113765A2 publication Critical patent/WO2005113765A2/fr
Publication of WO2005113765A3 publication Critical patent/WO2005113765A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des procédés de production de protéines de sulfatases activées. L'invention concerne également des méthodes et des compositions d'utilisation de ces protéines activées dans le traitement de divers troubles.
PCT/US2005/014097 2004-05-06 2005-04-25 Procedes d'activation de sulfatases, methodes et compositions d'utilisation associees Ceased WO2005113765A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56854404P 2004-05-06 2004-05-06
US60/568,544 2004-05-06

Publications (2)

Publication Number Publication Date
WO2005113765A2 WO2005113765A2 (fr) 2005-12-01
WO2005113765A3 true WO2005113765A3 (fr) 2006-01-12

Family

ID=35428930

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/014097 Ceased WO2005113765A2 (fr) 2004-05-06 2005-04-25 Procedes d'activation de sulfatases, methodes et compositions d'utilisation associees

Country Status (1)

Country Link
WO (1) WO2005113765A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104540517A (zh) * 2012-06-29 2015-04-22 夏尔人类遗传性治疗公司 用于产生重组艾杜糖-2-硫酸酯酶的细胞

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985783B2 (en) * 2006-09-21 2011-07-26 The Regents Of The University Of California Aldehyde tags, uses thereof in site-specific protein modification
US7722865B2 (en) 2008-01-18 2010-05-25 Biomarin Pharmaceutical Inc. Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
WO2009091994A2 (fr) 2008-01-18 2009-07-23 Biomarin Pharmaceutical Inc. Fabrication d'enzymes de sulfatase lysosomales humaines hautement phosphorylées actives et leurs utilisations
US8729232B2 (en) 2008-03-27 2014-05-20 The Regents Of The University Of California Aldehyde tags, uses thereof in site-specific protein modification
US20120180148A1 (en) * 2011-01-07 2012-07-12 Jin Thong-Gyu Transgenic mouse model for developing enzyme replacement therapy for iduronate-2-sulfatase deficiency syndrome
KR101158673B1 (ko) * 2011-06-24 2012-07-03 주식회사 지씨바이오 재조합 인간 이듀로네이트-2-설파타아제를 포함하는 조성물, 제제 및 이의 제조방법
US20160145589A1 (en) 2011-06-24 2016-05-26 Green Cross Corporation Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
WO2013148323A1 (fr) * 2012-03-30 2013-10-03 Shire Human Genetic Therapies Procédés d'analyse et de préparation de compositions protéiques
EP2830642B1 (fr) * 2012-03-30 2019-08-28 Shire Human Genetic Therapies, Inc. Administration sous-cutanée d'iduronate 2-sulfatase
KR101380740B1 (ko) 2012-06-29 2014-04-11 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 이듀로네이트-2-설파타제의 정제
US20140004097A1 (en) 2012-06-29 2014-01-02 Shire Human Genetic Therapies, Inc. Method of producing recombinant iduronate-2-sulfatase
MX2018005785A (es) 2015-11-09 2019-04-04 Scherer Technologies Llc R P Conjugados de anticuerpo anti-cd22-maytansina y metodos de uso de los mismos.
US11208632B2 (en) 2016-04-26 2021-12-28 R.P. Scherer Technologies, Llc Antibody conjugates and methods of making and using the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHRISTIANSON T. ET AL.: "Overexpression of inactive arysulphatase mutants and in vitro activation by light-dependent oxidation with vanadate.", BIOCHEM. J., vol. 382, September 2004 (2004-09-01), pages 581 - 587, XP002992392 *
ZALK P. ET AL.: "ATP-binding sites in brain p97/VCP (valosin-containing protein), a multifunctional AAA ATPase.", BIOCHEM J., vol. 374, May 2003 (2003-05-01), pages 473 - 480, XP002992393 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104540517A (zh) * 2012-06-29 2015-04-22 夏尔人类遗传性治疗公司 用于产生重组艾杜糖-2-硫酸酯酶的细胞

Also Published As

Publication number Publication date
WO2005113765A2 (fr) 2005-12-01

Similar Documents

Publication Publication Date Title
WO2005105780A3 (fr) Compositions utiles en tant qu'inhibiteurs de la rock et d'autres proteines kinases
AU2003202259A1 (en) Lipid compositions, production thereof and of esters
WO2005113765A3 (fr) Procedes d'activation de sulfatases, methodes et compositions d'utilisation associees
WO2005028475A3 (fr) Compositions utiles pour inhiber des proteines kinases
WO2004091572A3 (fr) Compositions contenant des structures cochleaires, dirigees contre l'expression de proteines
WO2006050477A3 (fr) Compositions antimicrobiennes et procedes de fabrication et d'utilisation
WO2004080406A3 (fr) Compositions therapeutiques
WO2005110396A3 (fr) Lipides nitres et procedes de fabrication et d'utilisation associes
EP2270037A3 (fr) Facteur IX hasylés
WO2007067504A3 (fr) Composes lactames et procedes d'utilisation de ceux-ci
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
WO2007125105A3 (fr) Activateurs de la glucokinase benzamidique
AU2006305225A8 (en) Wig and method of producing the same
WO2006063055A3 (fr) Conjugues enzymatiques utilises en tant qu'agents detoxifiants
AUPS017702A0 (en) Methods and compositions for the treatment of asthma and related disorders
EP2305821A3 (fr) Variants de protéases
EP1613269A4 (fr) Compositions, procedes et kits relatifs au clivage de her-2
WO2007101106A3 (fr) Compositions et méthodes pour moduler une hémostase au moyen de différentes formes de facteur v activé
WO2007067784A3 (fr) Compositions liposomales
WO2004030634A3 (fr) Compositions therapeutiques
WO2007025146A3 (fr) Preparations de balsalazide, leur procede d'obtention et leurs utilisations
AU2001268232A1 (en) Compositions, methods, and kits relating to resistin-like molecules
WO2004073686A3 (fr) Solutions de medicaments dans du menthol
WO2006063031A3 (fr) Variants alleliques du facteur viii humain
WO2007064304A8 (fr) Composition biocompatible et utilisations de celle-ci

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase